414867-62-2

Upstream product

• 220536-10-7 2-(4-Methoxy-phenyl)-2-(4-nitro-imidazol-1-yl)-propionic acid ethyl ester 
• 220529-51-1 (methoxy-phenyl)-(4-nitro-imidazol-1-yl)-acetic acid ethyl ester 
• 414867-64-4 2-(4-methoxy-phenyl)-2-(4-nitro-imidazol-1-yl)-propionic acid 
• 14062-18-1 ethyl p-methoxyphenylacetate 
• 220907-93-7 3-[2-(4-methoxy-phenyl)-2-(4-nitro-imidazol-1-yl)-propionyl]-4-methyl-5-phenyl-oxazolidin-2-one 
• 77629-83-5 ethyl 2-bromo-2-(4-methoxyphenyl) acetate 

Downstream Products

• 811795-90-1 [1-(1-{1-[1-(4-methoxy-phenyl)-1-methyl-2-oxo-2-pyrrolidin-1-yl-ethyl]-1H-imidazol-4-ylcarbamoyl}-4-phenyl-butylcarbamoyl)-1-methyl-ethyl]-carbamic acid tert-butyl ester 
• 811795-87-6 2-(4-methoxy-phenyl)-2-(4-nitro-imidazol-1-yl)-1-pyrrolidin-1-yl-propan-1-one 

Relevant academic research and scientific papers

Synthesis and biological evaluation of an orally active ghrelin agonist that stimulates food consumption and adiposity in rats

LY444711 is an orally active ghrelin agonist that binds with good affinity and is a potent activator of the growth hormone secretagogue receptor 1a (GHS-R1a) receptor. In rat models of feeding behavior and pharmacology, LY444711 creates a positive energy